At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 1,332 enrolled
Drug / intervention
Test culture +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Granulocyte-macrophage Colony Stimulating Factor (GM-CSF) During in Vitro Culture of Human Embryos on Subsequent Implantation Rates.
In Brief
A Phase 3 clinical trial evaluating Test culture and Control culture for Infertility. Completed, enrolled 1,332 participants across 14 sites in 2 countries.
Detailed Summary
This study is to assess whether addition of 2 ng/ml GM-CSF into a specific culture medium will increase the chance of a pregnancy after in vitro fertilisation.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfertility
CountriesDenmark, Sweden
Collaborators--
Timeline
Phase 3CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2007
First PostedNov 2007
Primary CompletionNov 2010
Study CompletionSep 2011
TodayJul 2026
First PostedNov 30, 2007
Enrollment StartNov 1, 2007
Primary CompletionNov 1, 2010
Study CompletionSep 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 18.6 years ago
Interventions
Test culturedevice
A standard culture medium with added GM-CSF (ready-to-use)
Control culturedevice
The same standard culture medium, but without any additions (ready-to-use)